 2. Assess the incidence of acute deep venous thrombosisDVT alone in patients with hereditary antithrombin AT deficiency in situations usually associated with a high risk for thromboembolic events after increasing and targeting functional AT activity at 80 and 120 of normal by prophylactic IV administration of rhAT. 